Christopher Hite
Vice Chairman
Chairman
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,323,000 | $1,323,000 |
| 2024 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,260,000 | $1,260,000 |
| 2023 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,200,000 | $4,560,000 |
Executive changes
Earnings-call appearances
-
Royalty Pharma at the Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q1 FY2026 Earnings Call2026-05-06
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q4 FY2025 Earnings Call2026-02-11
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q3 FY2025 Earnings Call2025-11-05
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q4 FY2024 Earnings Call2025-01-10
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q1 FY2024 Earnings Call2024-05-09
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q3 FY2023 Earnings Call2023-11-08
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q4 FY2022 Earnings Call2023-01-09
Royalty Pharma plc (RPRX)
-
Royalty Pharma plc Q3 FY2022 Earnings Call2022-11-08
Royalty Pharma plc (RPRX)